PHSA 03781 - Sebia Capillarys Electrophoresis System

Notice is hereby given that Interior Health Authority (the "Health Authority"), through their agent Provincial Health Services Authority ("PHSA"), intends to directly award a Contract to the following supplier to provide a Sebia Capillarys Electrophoresis System at an estimated value of $130,788.00 inclusive of taxes.

Somagen# Diagnostics Inc.
9220 - 25 Avenue Edmonton,
AB, T6N 1E1
Canada

PHSA, as agent for the Health Authority(s) has chosen not to proceed with a competitive process for the following reason:

· to ensure compatibility with existing products/systems, exclusive rights, copyright/patent rights, or to sustain specialized products that must be maintained by the manufacturer or its representative

The Kelowna General Hospital (KGH) Microbiology Laboratory are currently standardized to the Sebia Capillarys Electrophoresis System for primary analysis of protein and urine protein electrophoresis. Due to increased throughput KGH requires a second Sebia Capillarys Electrophoresis System. It is imperative to maintain consistent standards of care and standard operating procedures within the Interior Health Authority. This will ensure optimization of workflow, accurate results and maintain consistent standards of care throughout the Interior Health Authority.

Somagen# Diagnostics Inc. is the sole Canadian distributor of Sebia Capillary Electrophoresis System in Canada.

Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Kylie Burrage, Buyer, by email before 12:00pm Pacific Time, February 2, 2021. PHSA will review any and all issues received by this date and provide due consideration to each objection.

Please Reference File: # PHSA 03781 on all written correspondence.